Arcus Biosciences grants new hires options for 9,150 shares, awards 4,600 RSUs
RCUS•Arcus Biosciences granted two new hires options covering 9,150 shares and restricted stock units for 4,600 shares. The options have an exercise price of $23.83, equal to the Oct. 8, 2026 closing price.
1. Inducement equity grants
Arcus Biosciences issued employment inducement equity grants to two new hires under its 2020 Inducement Plan. The stock options cover 9,150 shares at an exercise price of $23.83, set at the Oct. 8, 2026 close, and the restricted stock units cover 4,600 shares of common stock.
